Ursodeoxycholic acid
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Ursodeoxycholic acid and local guidelines before prescribing.
Bile acid
Mechanism
Hydrophilic bile acid reducing cholesterol saturation and protecting hepatocytes.
Uses
Primary biliary cholangitis, gallstone dissolution, intrahepatic cholestasis of pregnancy.
Dosing
- Ursodeoxycholic acid - a bile acid that improves bile flow; first-line for primary biliary cholangitis (13–15 mg/kg/day - improves survival); second-line PBC drugs (e.g. PPAR agonists such as elafibranor or seladelpar) are specialist.
Gastroenterology: Anatomy Physiology Pharmacology - Ursodeoxycholic acid (UDCA) 13–15 mg/kg/day for life - slows progression.
Gastroenterology: Liver disease - Ursodeoxycholic acid 13–15 mg/kg/day | PBC first line, for life; check response at 12 months.
Gastroenterology: Liver disease - UDCA 13–15 mg/kg/day; check response at 12 months; second-line elafibranor or seladelpar if inadequate.
Gastroenterology: Liver disease
Side effects
Diarrhoea, nausea, rare hepatic reactions.
Interactions
Aluminium antacids and cholestyramine reduce absorption.
Contraindications and cautions
Acute cholecystitis, biliary obstruction
Monitoring
ALP, LFT
Pregnancy and breastfeeding
Used for cholestasis in pregnancy
Renal and hepatic impairment
Caution in liver disease
Overdose and reversal
Supportive
Special advice
Lifelong in PBC; check response with ALP.
More from the textbook: uses, cautions and other points
- Ursodeoxycholic acid | First-line for primary biliary cholangitis.
Gastroenterology: Anatomy Physiology Pharmacology - UDCA is no longer routinely recommended to improve outcomes (PITCHES trial), but it can be used for itch.
Gastroenterology: Liver disease - Ursodeoxycholic acid - also used to dissolve small cholesterol gallstones (rarely; slow and stones recur) and to prevent stones after rapid weight loss.
Gastroenterology: Anatomy Physiology Pharmacology - Ursodeoxycholic acid can dissolve small cholesterol stones, but it is slow and they recur - rarely used.
Gastroenterology: Pancreas and Biliary - Ursodeoxycholic acid | Dissolves small cholesterol stones (rarely used); prevents stones after rapid weight loss in some.
Gastroenterology: Pancreas and Biliary - No proven drug treatment . UDCA is used by some, but high doses are harmful.
Gastroenterology: Liver disease - PBC: women, AMA, ALP - UDCA. PSC: men with UC, MRCP beading - cholangiocarcinoma and colon cancer surveillance.
Gastroenterology: Liver disease - Itch relief - emollients with menthol, antihistamines (chlorphenamine for sleep). Ursodeoxycholic acid may help itch but doesn't reduce stillbirth.
Obstetrics: Medical Problems
Where it is discussed in the book
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Pancreas and Biliary (2 mentions)
- Gastroenterology: Liver disease (6 mentions)
- Obstetrics: Medical Problems (3 mentions)
- Biochemistry: Clinical biochemistry - interpreting laboratory tests (1 mention)